Back to funds
View filing
Birchview Capital, LP
hedge fundUpdated 28 days agoManaged by Birchview Capital, Lp • Latest filing Q2 2026
Portfolio value
$213.8M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
19.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $127.7M |
| Q2 2023 | $133.4M |
| Q3 2023 | $117.5M |
| Q4 2023 | $127.5M |
| Q1 2024 | $122.5M |
| Q2 2024 | $108M |
| Q3 2024 | $115.2M |
| Q4 2024 | $122.7M |
| Q1 2025 | $115.2M |
| Q2 2025 | $100.7M |
| Q3 2025 | $132.4M |
| Q4 2025 | $170.8M |
| Q1 2026 | $175.7M |
| Q2 2026 | $213.8M |
Top holdings
73 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KLAC KLA CORPORATION | $53.8M | 178.5K | 25.18% | — |
| 2 | C CELG-RI BRISTOL-MYERS SQUIBB CO | $17.1M | 297.2K | 8.01% | — |
| 3 | L LRCX LAM RESEARCH CORPORATION | $15.2M | 35.0K | 7.09% | — |
| 4 | S SLDB SOLID BIOSCIENCES INC | $6.7M | 666.2K | 3.11% | — |
| 5 | N NTLA INTELLIA THERAPEUTICS INC | $6.5M | 385.4K | 3.05% | — |
| 6 | B BDSX BIODESIX INC | $6.5M | 286.8K | 3.02% | — |
| 7 | S STOK STOKE THERAPEUTICS INC | $5.8M | 178.1K | 2.73% | — |
| 8 | O OVV OVINTIV INC | $5.7M | 107.5K | 2.65% | — |
| 9 | N NKTR NEKTAR THERAPEUTICS | $5.7M | 81.0K | 2.64% | — |
| 10 | C CORT CORCEPT THERAPEUTICS INC | $5M | 57.2K | 2.33% | — |
| 11 | N NBIX NEUROCRINE BIOSCIENCES INC | $4.6M | 27.2K | 2.14% | — |
| 12 | P PRTA PROTHENA CORP PLC | $4.4M | 449.0K | 2.06% | — |
| 13 | A ACAD ACADIA PHARMACEUTICALS INC | $4.3M | 171.0K | 2.02% | — |
| 14 | P PB PROTAGONIST THERAPEUTICS INC | $4.3M | 35.0K | 2.01% | — |
| 15 | ? N/A COMPASS THERAPEUTICS INC | $3.7M | 1.68M | 1.72% | — |
| 16 | R RLMD RELMADA THERAPEUTICS INC | $2.8M | 408.1K | 1.32% | — |
| 17 | A ALKS ALKERMES PLC | $2.6M | 50.0K | 1.23% | — |
| 18 | H HALO HALOZYME THERAPEUTICS INC | $2.6M | 33.3K | 1.22% | — |
| 19 | C CLDX CELLDEX THERAPEUTICS INC | $2.6M | 69.9K | 1.22% | — |
| 20 | C CYTK CYTOKINETICS INC | $2.6M | 30.0K | 1.20% | — |